| Sanofi-Aventis (Suisse) SA - Aubagio 14 mg QOD, comprimés pelliculés |
| 62761 | | 02 | | Aubagio 14 mg QOD | | comprimés pelliculés | | L04AA31 | | Teriflunomide | | 17.12.2021 | | |
|
| Composition |
| Comprimé pelliculé: teriflunomidum 14 mg, color.: E 132, excipiens pro compresso obducto. |
| Packungsbestandteile |
| Coated tablets | | | | | | | | Active Agent | Dose | additional_information |
|---|
| Teriflunomidum | 14 mg | Comprimé pelliculé |
| | BAG: Active Agent | Dose |
|---|
| Teriflunomidum | 14 mg |
| | | | Inactive agents | | additional_information |
|---|
| E 132 | | color. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 28 | 549.19 | 613.70 | B | SL | Yes |
|
